Portfolio Lab

Quest Diagnostics Inc

  • Stock
  • Ticker DGX
  • ISIN US74834L1008
  • NYSE

Health care · Health care services · USA

$258.28 −0.31%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Quest Diagnostics Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

DGXGlobal equities (VT)

$10,000 grew to $36,001. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −36.6% in 04/2020, measured from the peak in 03/2020. It took 2 months to get back to the old peak.

1-year return
+40.0%
5-year return p.a.
+13.9%
10-year return p.a.
+13.7%
Volatility p.a.
25.9%
Largest decline
−36.6%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue2,6212,6522,7612,8162,8062,8953,0433,097
Gross profit8588639439499109421,0271,042
Operating income361346438386386399459479
EBITDA496486581528531546605626
Net income222220282245245252320312
Earnings per share1.951.942.472.162.182.242.842.78
Balance sheet
Total assets16,15315,79715,96916,19716,22516,67316,93917,221
Liabilities9,3408,8358,7048,9029,0199,0079,1209,271
Equity6,7786,9297,2287,2587,1707,3667,5167,632
Cash549188319432420393626797
Long-term debt5,615–––5,167–5,6325,540
Cash flow
Operating cash flow464314544563465278597611
Capital expenditure-123-117-108-144-158-114-138-166
Free cash flow341197436419307164459445

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2021 at +47.9%, weakest 2018 at −13.8%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
23 Oct 2026$2.78
23 Jul 2026$2.84
22 Apr 2026$2.24
26 Feb 2026$2.18
21 Oct 2025$2.16
23 Jul 2025$2.47
23 Apr 2025$1.94
20 Feb 2025$1.95
23 Oct 2024$1.99
24 Jul 2024$2.03
24 Apr 2024$1.72
22 Feb 2024$1.70

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€26bn
Market cap in trading currency
$28.4bn
Enterprise value
$33.2bn
P/E
25.7
P/S
2.40
P/B
3.72
EV/Sales
2.80
EV/EBITDA
14.4
Earnings yield
3.9%
FCF yield
4.8%

Results (last four quarters)

Revenue
$11.8bn
Gross profit
$3.92bn
EBITDA
$2.31bn
Net income
$1.13bn
Earnings per share
$10.04
Revenue per share
$107.63
Revenue growth
+10.0%
Earnings growth
+27.3%

Profitability

Gross margin
33.1%
Operating margin
14.6%
Net margin
9.5%
Return on equity
15.2%
Return on assets
6.6%

Balance sheet and cash flow

Cash
$797m
Cash per share
$7.24
Financial debt
$5.55bn
Debt/equity %
73
Current ratio
1.70
Book value per share
$69.37
Operating cash flow
$1.95bn
Free cash flow
$1.38bn

Dividend

Dividend yield
1.31%
Dividend (12 months)
$3.38
Yield (12 months)
1.31%
Payout ratio
34%
Ex-dividend date
6 Oct 2026

Shares and trading

Shares outstanding
110m
Volume
1.37m
Avg. volume 3 months
1.03m
Relative volume
1.3

Price and technicals

Price
$258.28
1 day
−0.3%
52-week high
$262.21
52-week low
$173.49
Distance to 52-week high
−1.5%
Distance to 52-week low
+48.9%
Distance to 50-day line
+6.0%
Distance to 200-day line
+18.8%
RSI (14)
61
Volatility 1M
20.8%

Performance

1 week
−0.5%
1 month
+6.2%
3 months
+5.9%
6 months
+32.3%
YTD
+48.8%
1 year
+38.9%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has DGX performed since 11/2016?

$10,000 grew to $36,001 by 20 Nov 2026, which is +13.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is DGX?

Volatility was 25.9% per year, measured on monthly returns. The largest decline from a peak was −36.6%, with the low in 04/2020.

How does DGX compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, DGX returned +13.7% at 25.9%. The correlation of monthly returns was 0.45; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Quest Diagnostics Inc (DGX): Return and risk | Portfolio Lab